This article is more than 2 year old.

Dr Lal Path Labs to focus on inorganic growth, says CFO Goel

Mini

Dr Lal Pathlabs has made two acquisitions in Indore, Madhya Pradesh. Ved Goel, CFO at Dr Lal Pathlabs, in an interview with CNBC-TV18 shared the rationale behind these acquisitions.

Dr Lal Path Labs has made two acquisitions in Indore, Madhya Pradesh. Ved Goel, CFO at Dr Lal Pathlabs, in an interview with CNBC-TV18 shared the rationale behind these acquisitions.
“Strategically it makes sense to strengthen the presence of the company in MP. We will be acquiring this 70 percent stake for not more than Rs 50 crore,” said Goel on Tuesday.
"The acquisition will be completed in 2-3 months", he said.
"Moreover, inorganic is another way of growing because organically, the company is growing at 14-15 percent and globally too the next phase is consolidation. We would be looking at small labs in terms of consolidation especially in South and West where Dr Lal Pathlabs does not have much presence to strengthen the footprints, make presence stronger", said Goel.

Market Movers

CompanyPriceChng%Chng
Hindalco458.10 41.80 10.04
Tata Steel1,458.60 93.60 6.86
Bajaj Finserv14,599.05 628.50 4.50
SBI441.55 16.05 3.77
JSW Steel748.40 26.70 3.70
CompanyPriceChng%Chng
Tata Steel1,459.00 93.85 6.87
Bajaj Finserv14,590.45 625.20 4.48
SBI441.75 16.30 3.83
HCL Tech1,007.60 24.95 2.54
Sun Pharma703.25 15.70 2.28
CompanyPriceChng%Chng
Hindalco458.10 41.80 10.04
Tata Steel1,458.60 93.60 6.86
Bajaj Finserv14,599.05 628.50 4.50
SBI441.55 16.05 3.77
JSW Steel748.40 26.70 3.70
CompanyPriceChng%Chng
Tata Steel1,459.00 93.85 6.87
Bajaj Finserv14,590.45 625.20 4.48
SBI441.75 16.30 3.83
HCL Tech1,007.60 24.95 2.54
Sun Pharma703.25 15.70 2.28

Currency

CompanyPriceChng%Chng
Dollar-Rupee74.2850-0.0900-0.12
Euro-Rupee88.1740-0.0370-0.04
Pound-Rupee103.68300.15700.15
Rupee-100 Yen0.6763-0.0003-0.04